Muller & Phipps (India) Limited (BOM:501477)

India · Delayed Price · Currency is INR

217.25

+8.25 (3.95%)

At close: Sep 11, 2026

Market Cap	135.78M -16.9%
Revenue (ttm)	67.05M +1.0%
Net Income	-6.30M
EPS	-10.08
Shares Out	625.00K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	105
Open	210.00
Previous Close	209.00
Day's Range	210.00 - 218.70
52-Week Range	188.10 - 264.00
Beta	-0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Muller & Phipps (India)

Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; dental and skincare products under the Cavidine and Nixoderm brand name. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. The Muller & Phipps (India) Limited is a subsidiary of Deve... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1917

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 501477

Full Company Profile

Financial Performance

In fiscal year 2026, Muller & Phipps (India)'s revenue was 58.84 million, a decrease of -5.02% compared to the previous year's 61.94 million. Losses were -475,000, -93.72% less than in 2025.

Financial Statements